manufacturing - search results

M&A activity remains at a six year high, according to the Transaction Services group of PricewaterhouseCoopers, buoyed by record cash levels at corporations and private equity firms, plentiful financing and historically low levels of troubled commercial debt.

The ACG/Thomson DealMaker's survey records high confidence level by M&A Professionals. This year is on track for a record M&A year, while active buy-out firms are still fuelling a booming M&A market.

With $25.39bn invested after the first three quarters of the year, venture capital activity in the US, Europe, China and Israel in 2006 is poised to hit a five-year high and register the highest annual investments since 2001, according to a global year end analysis by VentureOne and Ernst & Young. This year, investment is expected to top $32bn after the fourth quarter.

India is set to become a regional hub for R&D, manufacturing and exporting, says KPMG. Multi-national companies are returning, but they believe considerable regulatory and infrastructure challenges remain.

Cleantech is poised to add to economic growth if IPO and M&A trends continue. In this IVCJ article, Nicholas Parker, co-founder and chairman of the Cleantech Capital Group LLC, along with Candace Stuart, Cleantech Capital’s director of publications, explain why.

Innovation in advanced water solutions has been synonymous with Israel for many years. In this IVCJ article, Mira Rashty, general manager of Waterfronts – Israel Water Alliance examines several water segments where Israeli companies are making waves.

In this IVCJ article, Bic Stevens, managing partner at Ardour Capital Investments, answers frequently asked questions about raising capital for alternative energy companies.

Japan has risen to the forefront of countries developing environmental technologies, says the IVCJ. In this article, Harel-Hertz Investment House’s Manager of Business Development, Liron Neugarten, and Market Research Specialist, Reut Harari, examine the moves being made in Japan toward growing the clean technology market.

Clal Biotech CEO Ruben Krupik had been seeking a means of bringing drugs from the early development stage to market, says the Israel Venture Capital Journal. Teaming with Teva Pharmaceutical may well turn out to be the best answer. Avida Landau explains.

In April 2006, the IVC Research Center hosted a roundtable discussion with leading Taiwanese businessmen to discuss challenges to Taiwan’s technology companies, hot areas for the future, and potential technology collaborations in Israel.